The seroepidemiology of measles in Western Europe

被引:50
作者
de Melker, H
Pebody, RG
Edmunds, WJ
Lévy-Bruhl, D
Valle, M
Rota, MC
Salmaso, S
van den Hof, S
Berbers, G
Saliou, P
Conyn-van Spaendonck, M
Crovari, P
Davidkin, I
Gabutti, G
Hesketh, L
Morgan-Capner, P
Plesner, AM
Raux, M
Tischer, A
Miller, E
机构
[1] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[2] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England
[3] Reseau Natl Sante Publ, Paris, France
[4] Natl Publ Hlth Inst, Helsinki, Finland
[5] Inst Super Sanita, Rome, Italy
[6] Aventis Pasteur, Paris, France
[7] Univ Genoa, Dept Hlth Sci, Hyg & Prevent Med Sect, Fac Med, I-16126 Genoa, Italy
[8] Univ Lecce, Fac Sci, Dept Biol, Hyg Lab, I-73100 Lecce, Italy
[9] Preston Publ Hlth Lab, Preston, Lancs, England
[10] Statens Serum Inst, DK-2300 Copenhagen, Denmark
[11] Robert Koch Inst, D-1000 Berlin, Germany
关键词
D O I
10.1017/S0950268801005234
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The European Regional Office of WHO has targeted measles for elimination from the region in 2007. Large national, age and sex stratified serological surveys of measles antibody were conducted in seven Western European countries from 1994-8 as part of the European Seroepidemiology Network. Three patterns were observed in the country-specific measles seroprofiles, ranging from (very) low susceptibility (four countries) to high susceptibility (one country). Susceptibility levels amongst 2-4-year-olds ranged from 2.9 to 29.8%, in 5-9-year-olds from 2.5 to 25% and 10-19-year-olds from 2.1% to 13.9%. A country's susceptibility profile was highly associated with vaccine coverage for the first dose. First dose coverage ranged from 91 to 97.5 % for low susceptibility countries, 75 to 85 % for intermediate susceptibility countries and 55 % for the high susceptibility country. Only the high susceptibility country still reports epidemic measles. In low susceptibility countries, which have achieved or are very close to measles elimination, the priority will be to maintain high MMR vaccine coverage in all geopolitical units for both vaccine doses. In moderate susceptibility countries there is still some endemic transmission, but also risk of outbreaks as pools of susceptibles accumulate. In the high susceptibility country the priority will be to increase infant vaccine coverage and reduce regional variation in coverage levels.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 24 条
  • [1] ANDREWS N, IN PRESS EPIDEMIOL I
  • [2] [Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P1049
  • [3] SUCCESSES AND FAILURES IN MEASLES CONTROL
    CUTTS, FT
    MARKOWITZ, LE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 : S32 - S41
  • [4] Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts
    Davidkin, I
    Valle, M
    [J]. VACCINE, 1998, 16 (20) : 2052 - 2057
  • [5] DUCLOS P, 1994, CAN J PUBLIC HEALTH, V85, P278
  • [6] EDMUNDS WJ, IN PRESS EPIDEMIOL I
  • [7] Gay N, 1997, Commun Dis Rep CDR Rev, V7, pR17
  • [8] GAY N, IN PRESS EPIDEMIOL I
  • [9] GERIKE G, 1997, EUROSURVEILLANCE, V2, P88
  • [10] MEASLES OUTBREAK IN A FULLY IMMUNIZED SECONDARY-SCHOOL POPULATION
    GUSTAFSON, TL
    LIEVENS, AW
    BRUNELL, PA
    MOELLENBERG, RG
    BUTTERY, CMG
    SEHULSTER, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) : 771 - 774